Publications

Huang Q, Anandasabapathy N.  2020.  Ex vivo assessment of in vivo DC-targeted antibodies in pre-clinical models.. Methods Enzymol. 632:417-430.

Anandasabapathy N.  2015.  Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteer. Bone Marrow Transplantation. 50(7):924-930.

Anandasabapathy N.  2003.   An E3 Ubiquitin Ligase that Inhibits Cytokine Gene Transcription Is Expressed in Anergic CD4+ T Cells. Cell Immunity. :535-547.